First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain.
Authors
Yang X, Zhu R, Zhang J, Hou Z, Yang L, Fan X, Yan Q, Li J, Zhou Z, Fang P
Abstract
The study aimed to investigate the safety, pharmacokinetics (PK), and efficacy of YJ001 spray, a candidate drug for diabetic neuropathic pain (DNP) therapy.
